Evolution of prevention of vertical HIV transmission in Uganda: 2008–2017
HIV Medicine · 2023-05 · 24 (5) · 605-615
DOI: 10.1111/hiv.13449 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift HIV Medicine, online erschienen am 30.11.2022. Verfasst von Marissa Nahirney und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada. Hauptthemen laut MEDLINE: HIV Infections, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Women and Children's Health Research Institute.
Abstract (Originalsprache)
Objectives
Uganda adapted its policy for prevention of vertical transmission (VT) of HIV transmission as the World Health Organization released Options A, B and B+. We assessed trends in diagnostic testing, breastfeeding practices, maternal and infant antiretroviral therapy (ART), mortality, VT and HIV‐free survival (HFS) among Ugandan infants born to women living with HIV during this period of successive guideline changes.
Methods
This is is a retrospective observational study of infants attending early infant diagnosis clinics at two Ugandan hospitals.
Results
A total of 1885 infants (48% female) were managed from 2009 to 2017. DNA polymerase chain reaction (PCR) for early infant diagnosis was performed on 1719 infants (92%, one or more PCR tests) and 676 infants (36%, two PCR tests). HIV serology was performed on 90 infants (4.8%). Testing increased over the study period but remained suboptimal, due to high loss to follow‐up (LTFU). A total of 93% of infants were breastfed, for a median of 9.5 months. The duration of breast milk exposure increased over the study period, consistent with guidelines that increasingly encouraged breastfeeding. Nine cases (0.48%) of suspected breast milk transmission were observed. The use of ART increased significantly over the study period. Mortality (3.5%, 2.7% and 1.1%; p = 0.0076) and VT (17%, 12% and 7.4%; p < 0.0001) decreased over the study period (2008–2010, 2011–2012 and 2013–2017, respectively). LTFU values were 31%, 49% and 59% at 6, 12 and 18 months of age, respectively, with only modest improvements over time. HFS could only be conclusively documented in 532 infants (28%) because of LTFU.
Conclusions
From 2009 to 2017, outcomes improved among HIV‐exposed infants in Uganda. LTFU remains a barrier to optimal care.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pediatrics, University of Alberta, Edmonton, Alberta, Canada.
- Kabale Regional Referral Hospital, Kabale, Uganda.
- Department of Pediatrics, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, Ontario, Canada.
- Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada.
- Department of Global Health, School of Public Health, University of Alberta, Edmonton, Alberta, Canada.
- Distinguished Researcher, Stollery Science Lab, University of Alberta, Edmonton, Alberta, Canada.
ORCID-Profile: Michael T Hawkes
Förderung
- Women and Children's Health Research Institute
Zitieren
APA
Nahirney, M., Grist, J., Namasopo, S., Brophy, J., & Hawkes, M. T. (2023). Evolution of prevention of vertical HIV transmission in Uganda: 2008–2017. HIV Medicine, 24(5), 605-615. https://doi.org/10.1111/hiv.13449
Vancouver
Nahirney M, Grist J, Namasopo S, Brophy J, Hawkes MT. Evolution of prevention of vertical HIV transmission in Uganda: 2008–2017. HIV Medicine. 2023;24(5):605-615. doi:10.1111/hiv.13449
BibTeX
@article{Nahirney2023,
author = {Nahirney, Marissa and Grist, Jesse and Namasopo, Sophie and Brophy, Jason and Hawkes, Michael T},
title = {Evolution of prevention of vertical HIV transmission in Uganda: 2008–2017},
journal = {HIV Medicine},
year = {2023},
volume = {24},
number = {5},
pages = {605--615},
doi = {10.1111/hiv.13449}
}
EUVIMED